Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 2408645, 8 pages
http://dx.doi.org/10.1155/2016/2408645
Research Article

Association between Tumor Vasculogenic Mimicry and the Poor Prognosis of Gastric Cancer in China: An Updated Systematic Review and Meta-Analysis

1Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medicine Sciences, No. 5 Beixiange, Xicheng District, Beijing 100053, China
2Beijing University of Chinese Medicine, No. 11 North Third Ring Road East, Chaoyang District, Beijing 100029, China

Received 17 June 2016; Accepted 3 August 2016

Academic Editor: Wan-Liang Lu

Copyright © 2016 Qiujun Guo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. W. Stewart and C. P. Wild, “World cancer report 2014,” World Health Organization, 2015, http://apps.who.int/bookorders/anglais/detart1.jsp?codlan=1&codcol=80&codcch=275
  2. Z. X. Zheng, R. S. Zheng, S. W. Zhang, and W. Q. Chen, “An analysis of incidence and mortality of stomach cancer in China, 2010,” China Cancer, vol. 23, no. 10, pp. 795–800, 2010. View at Publisher · View at Google Scholar
  3. W. Chen, R. Zheng, P. D. Baade et al., “Cancer statistics in China, 2015,” CA: A Cancer Journal for Clinicians, vol. 66, no. 2, pp. 115–132, 2016. View at Publisher · View at Google Scholar
  4. J.-H. Lee, H.-I. Kim, M. G. Kim, T. K. Ha, M.-S. Jung, and S. J. Kwon, “Recurrence of gastric cancer in patients who are disease-free for more than 5 years after primary resection,” Surgery, vol. 159, no. 4, pp. 1090–1098, 2016. View at Publisher · View at Google Scholar
  5. A. J. Maniotis, R. Folberg, A. Hesset et al., “Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry,” American Journal of Pathology, vol. 155, no. 3, pp. 739–752, 1999. View at Publisher · View at Google Scholar
  6. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Yang, B. Sun, X. Zhao et al., “Erythropoietin and erythropoietin receptor in hepatocellular carcinoma: correlation with vasculogenic mimicry and poor prognosis,” International Journal of Clinical & Experimental Pathology, vol. 8, no. 4, pp. 4033–4043, 2015. View at Google Scholar · View at Scopus
  8. C. I. Schnegg, M. H. Yang, S. K. Ghosh, and M.-Y. Hsu, “Induction of vasculogenic mimicry overrides VEGF-A silencing and enriches stem-like cancer cells in melanoma,” Cancer Research, vol. 75, no. 8, pp. 1682–1690, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Liu, B. Sun, X. Zhao et al., “OCT4 expression and vasculogenic mimicry formation positively correlate with poor prognosis in human breast cancer,” International Journal of Molecular Sciences, vol. 15, no. 11, pp. 19634–19649, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Ren, N. Yao, G. Wang et al., “Vasculogenic mimicry: a new prognostic sign of human osteosarcoma,” Human Pathology, vol. 45, no. 10, pp. 2120–2129, 2014. View at Publisher · View at Google Scholar
  11. Y. Zhang, M. M. Baocun Sun, M. B. Xiulan Zhaoet et al., “Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma,” Journal of Surgical Oncology, vol. 108, no. 6, pp. 414–419, 2013. View at Publisher · View at Google Scholar
  12. Z. Cao, M. Bao, L. Miele, F. H. Sarkar, Z. Wang, and Q. Zhou, “Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis,” European Journal of Cancer, vol. 49, no. 18, pp. 3914–3923, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Zhou, L. Yu, Z.-Z. Feng et al., “Aberrant expression of markers of cancer stem cells in gastric adenocarcinoma and their relationship to vasculogenic mimicry,” Asian Pacific Journal of Cancer Prevention, vol. 16, no. 10, pp. 4177–4183, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” PLoS Medicine, vol. 6, no. 7, Article ID e1000097, 2009. View at Google Scholar
  15. A. Liberati, D. G. Altman, J. Tetzlaff et al., “The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration,” The British Medical Journal, vol. 339, article b2700, 2009. View at Publisher · View at Google Scholar
  16. J. F. Tierney, L. A. Stewart, D. Ghersi, S. Burdett, and M. R. Sydes, “Practical methods for incorporating summary time-to-event data into meta-analysis,” Trials, vol. 8, no. 1, article 16, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Steels, M. Paesmans, T. Berghmans et al., “Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis,” European Respiratory Journal, vol. 18, no. 4, pp. 705–719, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. H. J. Chen, “Primary research of Vasculogenic Mimicry in gastric cancer tissue,” Database: China Dissertation Database, 2009 (Chinese), http://d.wanfangdata.com.cn/Thesis/J018372
  19. M. Li, Y. Gu, Z. Zhanget et al., “Vasculogenic mimicry: a new prognostic sign of gastric adenocarcinoma,” Pathology & Oncology Research, vol. 16, no. 2, pp. 259–266, 2009. View at Publisher · View at Google Scholar
  20. S. Liao and Q. Gao, “Expressions and clinical significance of vasculogenic mimicry and related protein Mig-7 and MMP-2 in gastric carcinoma,” Chinese Journal of Cellular and Molecular Immunology, vol. 29, no. 2, pp. 194–196, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. Y.-Y. Song, L.-D. Sun, M.-L. Liu et al., “STAT3, p-STAT3 and HIF-1α are associated with vasculogenic mimicry and impact on survival in gastric adenocarcinoma,” Oncology Letters, vol. 8, no. 1, pp. 431–437, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. H. L. Su, H. H. Su, P. X. Zhang, Q. Lin, K. Chen, and F. L. Liu, “The expression of c-Met and p-Akt in gastric cancer and their correlations with VM,” The Practical Journal of Cancer, vol. 30, no. 12, pp. 1771–1774, 2015 (Chinese). View at Publisher · View at Google Scholar
  23. X. Q. Wang, S. W. Zhang, X. Wang, and Q. Wu, “Pilot study of vasculogenic mimicry in gastric adenocarcinoma,” Acta Universitatis Medicinalis Anhui, vol. 5, pp. 709–711, 2010 (Chinese). View at Google Scholar
  24. Z. Yang, A preliminary study of vasculogenic mimicry in gastric cancer [M.S. thesis], Nanhua University, Chiayi, Taiwan, Database: China Dissertation Database, 2001, http://d.wanfangdata.com.cn/Thesis/D521263.
  25. Y. S. Zhang and H. Zhao, “Tumor vasculogenic mimicry in gastric sarcoma tissues,” China Foreign Fedical Trestment, vol. 30, no. 90, 2010 (Chinese). View at Google Scholar
  26. J. Y. Zhou, C. Xin, Y. P. Mouet et al., “Robotic versus laparoscopic distal pancreatectomy: a meta-analysis of short-term outcomes,” PLoS ONE, vol. 11, no. 3, Article ID e0151189, 2016. View at Publisher · View at Google Scholar
  27. B. Sun, S. Zhang, X. Zhao, W. Zhang, and X. Hao, “Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas,” International Journal of Oncology, vol. 25, no. 6, pp. 1609–1614, 2004. View at Google Scholar · View at Scopus
  28. A. Van Beurden, R. F. Schmitz, C. M. van Dijk, and C. I. Baeten, “Periodic acid Schiff loops and blood lakes associated with metastasis in cutaneous melanoma,” Melanoma Research, vol. 22, no. 6, pp. 424–429, 2012. View at Publisher · View at Google Scholar
  29. Z. Yang, B. Sun, X. Zhao et al., “Erythropoietin and erythropoietin receptor in hepatocellular carcinoma: correlation with vasculogenic mimicry and poor prognosis,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 4, pp. 4033–4043, 2015. View at Google Scholar · View at Scopus
  30. P. Lin, W. Wang, B. C. Sunet et al., “Vasculogenic mimicry is a key prognostic factor for laryngeal squamous cell carcinoma: a new pattern of blood supply,” Chinese Medical Journal, vol. 125, no. 19, pp. 3445–3449, 2012. View at Google Scholar
  31. Z. Liu, B. Sun, L. Qi, H. Li, J. Gao, and X. Leng, “Zinc finger E-box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial-to-mesenchymal transition,” Cancer Science, vol. 103, no. 4, pp. 813–820, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. W. Sun, Z.-Y. Shen, H. Zhang et al., “Overexpression of HIF-1α in primary gallbladder carcinoma and its relation to vasculogenic mimicry and unfavourable prognosis,” Oncology Reports, vol. 27, no. 6, pp. 1990–2002, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Wu, L. Yu, D. Wang et al., “Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry,” BMC Cancer, vol. 12, article 535, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Ren, N. Yao, G. Wang et al., “Vasculogenic mimicry: a new prognostic sign of human osteosarcoma,” Human Pathology, vol. 45, no. 10, pp. 2120–2129, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Liu, B. Sun, X. Zhao et al., “USP44+ cancer stem cell subclones contribute to breast cancer aggressiveness by promoting vasculogenic mimicry,” Molecular Cancer Therapeutics, vol. 14, no. 9, pp. 2121–2131, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. A. R. Hess, E. A. Seftor, R. E. B. Seftor, and M. J. C. Hendrix, “Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry,” Cancer Research, vol. 63, no. 16, pp. 4757–4762, 2003. View at Google Scholar · View at Scopus
  37. M. J. C. Hendrix, E. A. Seftor, P. S. Meltzer et al., “Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 14, pp. 8018–8023, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Wang, T. Sun, X. L. Zhao et al., “Functional significance of VEGF-a in human ovarian carcinoma: role in vasculogenic mimicry,” Cancer Biology & Therapy, vol. 7, no. 5, pp. 758–766, 2008. View at Publisher · View at Google Scholar
  39. L. Qin, Y. Ren, A.-M. Chen et al., “Peroxisome proliferator-activated receptor γ ligands inhibit VEGF-mediated vasculogenic mimicry of prostate cancer through the AKT signaling pathway,” Molecular Medicine Reports, vol. 10, no. 1, pp. 276–282, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. A. R. Hess, E. A. Seftor, L. M. G. Gardner et al., “Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2),” Cancer Research, vol. 61, no. 8, pp. 3250–3255, 2001. View at Google Scholar · View at Scopus
  41. W. Wang, P. Lin, B. Sun et al., “Epithelial-mesenchymal transition regulated by EphA2 contributes to vasculogenic mimicry formation of head and neck squamous cell carcinoma,” BioMed Research International, vol. 2014, Article ID 803914, 10 pages, 2014. View at Publisher · View at Google Scholar
  42. X.-S. Lu, W. Sun, C.-Y. Ge, W.-Z. Zhang, and Y.-Z. Fan, “Contribution of the PI3K/MMPs/Ln-5γ2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas,” International Journal of Oncology, vol. 42, no. 6, pp. 2103–2115, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Zang, Y. Zhang, B. Zhang et al., “CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1852, no. 5, pp. 1020–1028, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Wang, W. Sun, W.-Z. Zhang et al., “Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway,” PLoS ONE, vol. 9, no. 5, article e96982, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. X. L. Bai, Q. Zhang, L. Y. Ye et al., “Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling,” Oncogene, vol. 34, no. 31, pp. 4089–4097, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. X.-G. Mao, X.-Y. Xue, L. Wang et al., “CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia,” Neuro-Oncology, vol. 15, no. 7, pp. 865–879, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. H.-Y. Wan, Q.-Q. Li, Y. Zhang et al., “MiR-124 represses vasculogenic mimicry and cell motility by targeting amotL1 in cervical cancer cells,” Cancer Letters, vol. 355, no. 1, pp. 148–158, 2014. View at Publisher · View at Google Scholar · View at Scopus